Skip to content
S8966Senate2023-2024 SessionSame asA9235

Update Lab Certification Rules

Official title

“Relates to certificates of qualification for clinical laboratories and blood banks and work standards for cytotechnologists”

Sponsor Gustavo RiveraSD-33+1 co-sponsorAffects Health
Status
Senate Floor Calendar
Impact
6/10
Moderate
Outcome
Companion signed

Bill progress

Signed via A9235

What's happening

This bill updates qualifications and standards for clinical laboratory directors and cytotechnologists, aligning New York law with federal regulations.

Why it matters

  1. Aligns state qualifications for lab directors with federal standards. , potentially making it easier for qualified professionals from other states or federally certified individuals to become lab directors in New York, and ensuring consistency in regulatory expectations.

  2. Updates how cytotechnologist workloads are regulated. by removing New York’s specific numeric daily slide limits and instead requiring that state regulations be at least as stringent as federal ones. This could allow more flexibility in adapting to advances in lab technology and practices, while still protecting patient safety.

  3. Streamlines administrative requirements. for cytotechnologists by eliminating mandatory state registration and individual workload record-keeping, reducing paperwork and administrative burden for both professionals and labs.

  4. Raises the application and renewal fees for laboratory director certificates. from $40 to $150, which may have financial implications for professionals but could also provide more resources for regulatory oversight.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Clinical laboratory and blood bank directors

    The bill would tie certificate qualifications to federal requirements, including required board certification, remove procedure-specific certificate language and raise application and renewal fees from $40 to $150.

  • Cytotechnologists

    The bill would eliminate registration under this section and individual record-keeping requirements, while replacing statutory slide-examination limits with authority for workload regulations at least as stringent as federal rules.

  • Clinical laboratories employing cytotechnologists

    The bill would remove the requirement to employ only cytotechnologists registered under this section and simplify laboratory records while retaining duties to enforce applicable workload standards.

  • New York State Department of Health

    The bill would shift director qualification standards from state-prescribed testing-area qualifications to federal minimums and authorize cytotechnologist workload rules without the existing statutory slide limits.

Headline styles

Update Lab Certification Rules

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Gustavo Rivera

Senator · Senate District 33

Chair, Health

1 Co-sponsor

History

  1. Substituted by A9235A
  2. Advanced to third reading
  3. 2nd report cal.
  4. 1st report cal.998
  5. Print number 8966a
  6. Amend and recommit to health
  7. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A9235Assembly

Update Lab Work Standards

Signed by Governor · Sponsor Amy Paulin

Impact 6 · ModerateSigned into law

Full text

4 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

8966--A

IN SENATE

April 3, 2024

Introduced by Sen. RIVERA -- read twice and ordered printed, and when printed to be committed to the Committee on Health -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee

AN ACT to amend the public health law, in relation to certificates of qualification for clinical laboratories and blood banks

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Section 572 of the public health law, as amended by chapter 436 of the laws of 1993, is amended to read as follows:

§ 572. Certificates of qualification. No person shall act as a director in a clinical laboratory located in or accepting specimens from New York state or in a blood bank located in or collecting, processing, storing or distributing blood products in New York state unless a valid certificate of qualification has been issued as provided in section five hundred seventy-three of this title. [A certificate shall be issued authorizing the holder to perform or direct one or more procedures or one or more categories of such procedures.]

§ 2. Section 573 of the public health law, as amended by chapter 436 of the laws of 1993, is amended to read as follows:

§ 573. Issuance of certificates of qualification. 1. [The public health council shall prescribe minimum qualifications for directors in areas of testing, including, but not limited to, microbiology, immunology, chemistry, hematology, biophysics, cytology, pathology, genetics and blood banking.

2.] The department shall issue a certificate of qualification to any person who meets [such] prescribed minimum qualifications under federal regulations, including board certification as required and who otherwise demonstrates to the department that such person possesses the character, competence, training and ability to administer properly the technical and scientific operation of a clinical laboratory or blood bank, including supervision of procedures and reporting of findings of tests.

[3.] 2. Application for a certificate of qualification shall be made on forms provided by the department [and shall contain the procedures or

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD14434-05-4

categories of procedures for which the certificate is sought] and such other information as the department may require.

[4.] 3. The certificate shall be valid for a period of two years from the date of issuance and may be renewed for successive [two year] twoyear periods thereafter. The original application and each renewal application shall be accompanied by a registration fee of [forty] one hundred fifty dollars.

[5.] 4. Notwithstanding the provisions of this section, the commissioner may issue a temporary certificate of qualification to any person pending the issuance of a certificate as provided in this section. A temporary certificate shall be valid for a period of thirty days from the date of its issuance and may be renewed for a maximum of four successive periods of thirty days.

§ 3. Subdivision 2 of section 575 of the public health law, as amended by section 19 of part A of chapter 59 of the laws of 2011, is amended to read as follows:

2. A permit [or permit category] shall not be issued unless a valid certificate of qualification [in the category of procedures for which the permit is sought] has been issued [to the director] pursuant to the provisions of section five hundred seventy-three of this title, unless all fees and outstanding penalties, if any, have been paid, and the department finds that the clinical laboratory or blood bank is competently staffed and properly equipped, and will be operated in the manner required by this title.

§ 4. Section 576-a of the public health law, as amended by chapter 436 of the laws of 1993, is amended to read as follows:

§ 576-a. Clinical laboratories and cytotechnologists examining Pap smears. 1. Definitions. As used in this section, unless the context clearly requires otherwise, the following terms shall have the following meanings:

(a) "Cytotechnologist". A clinical laboratory professional specializing in the analysis of cytopathology samples, including Pap smears, for cervical cancer and related diseases who meets the qualifications specified by the department.

(b) "Cytotechnologist work standard". (i) A limitation on the number of Pap smears (also known as gynecologic slides) and non-gynecologic slides a cytotechnologist may examine during a particular time period, or other limitation on the quantity, speed or manner of examination of slides by a cytotechnologist, under regulations of the department.

(ii) [Unless otherwise provided by the department, the cytotechnologist work standard shall be: No cytotechnologist may examine more than eighty one-slide gynecologic cases or fifty two-slide gynecologic cases per work day. If a cytotechnologist also examines non-gynecologic slides in a given work day the cytotechnologist's workload for gynecologic slides shall be correspondingly reduced, in accordance with written guidelines prepared by the clinical laboratory and filed with the department, so that a cytotechnologist examines no more than a total of one hundred gynecologic and non-gynecologic slides per work day.] The department may establish regulations for cytotechnologist workload standards that shall be at least as stringent as federal regulations.

(c) "Employ". To employ or contract with a cytotechnologist to examine gynecologic slides.

(d) "Clinical laboratory". A clinical laboratory issued a permit pursuant to this title.

(e) "Work day". A twenty-four hour period during which a cytotechnologist examines gynecologic slides for a clinical laboratory.

2. Compliance with cytotechnologist work standard. No cytotechnologist shall exceed the applicable cytotechnologist work standard. No clinical laboratory shall require, authorize, encourage or permit any cytotechnologist to exceed the applicable cytotechnologist work standard. In determining whether a cytotechnologist exceeds the applicable cytotechnologist work standard, all work done by the cytotechnologist during a given work day shall be considered, without regard to which clinical laboratory or other person for which or whom it was performed.

3. [Registration of cytotechnologist. All cytotechnologists who are employed by a clinical laboratory must register with the department. The department shall, by regulation, prescribe a form and procedure for the registration of cytotechnologists. The registration form shall include at least the name, address, and an individual identification number determined by the department. The department shall notify each registrant of his or her identification number.

4. Employment of registered cytotechnologists. No clinical laboratory shall employ a cytotechnologist unless the cytotechnologist is registered under this section.

5.] Record-keeping. (a) Each clinical laboratory shall maintain records, in a form prescribed by the department, which set forth, for each cytotechnologist employed by the clinical laboratory:

(i) the name [and identification number] of the cytotechnologist;

(ii) the number of hours worked by the cytotechnologist in each work day;

(iii) the number of gynecologic slides and non-gynecologic slides examined by the cytotechnologist[, and how many were one-slide and twoslide cases,] during each work day; and

(iv) such other information as the department may require by regulation.

(b) [Each cytotechnologist shall maintain records, in a form prescribed by the department, which set forth:

(i) the number of hours worked by the cytotechnologist in each work day;

(ii) the number of gynecologic slides and non-gynecologic slides examined and how many were one-slide and two-slide cases, during each work day;

(iii) the name and address of the clinical laboratory or other person for which or whom the slides were examined; and

(iv) such other information as the department may require by regulation.

(c)] Such records of clinical laboratories and cytotechnologists shall be made available for inspection and copying by the department upon request.

[6.] 4. Multiple employers. Whenever a cytotechnologist is employed by more than one clinical laboratory or other person during a work day, the cytotechnologist shall advise each clinical laboratory of any previous employment during the work day and the amount of work performed, to insure that the applicable cytotechnologist work standard is not exceeded.

[7.] 5. Standards for gynecologic slides. (a) A gynecologic slide of a Pap smear shall not be tested or reported on if:

(i) the apparent condition of the specimen indicates that it is unsatisfactory for testing or that it is inappropriate for the test requested;

(ii) it has been collected, labeled, preserved or otherwise handled in such a manner that it has become unsatisfactory or unreliable as a test specimen;

(iii) the slide is broken;

(iv) it contains insufficient cells or the cells are obscured by inflammation, blood or lubricating ointment, so that an adequate diagnosis cannot be made; or

(v) the slide is otherwise unsatisfactory, as defined by department regulations.

(b) If the slide is unsatisfactory as set forth in this subdivision, the clinical laboratory shall have an affirmative duty to advise the collecting physician or other practitioner that the slide is unsatisfactory and request the submission of a new slide.

[8.] 6. Re-examination of slides. The department shall prescribe, by regulation, a system of targeted re-examination of gynecologic slides examined and found to be not abnormal or questionable. The factors to be considered in the targeted re-examination may include, but are not limited to, the prior cancer and other history of the patient, the results of previous slide examinations, and the experience and ability of the cytotechnologist. Each clinical laboratory shall follow the prescribed re-examination system.

[9. Regulations. The department may, by regulation, establish cytotechnologist work standards. Those standards may include, but shall not be limited to, standards which take into account the experience and qualifications of the cytotechnologists and the performance of the clinical laboratory in proficiency testing programs conducted by the department. However, those standards shall not exceed by more than twenty percent the maximum numbers of slides which may be examined in a work day under clause (ii) of paragraph (b) of subdivision one of this section. Such standards shall be at least as stringent as federal standards promulgated under the federal clinical laboratory improvement amendments of nineteen hundred eighty-eight.

10.] 7. Notwithstanding any provisions of [subdivisions] subdivision one [and nine] of this section to the contrary, the department may, pursuant to regulation, increase the maximum number of slides which may be examined in a work day for clinical laboratories using slide examination or preparation technology approved by the federal food and drug administration, provided that such standards shall be at least as stringent as federal standards promulgated under the federal clinical laboratory improvement amendments of nineteen hundred eighty-eight or other applicable federal law.

[11.] 8. Violations. (a) Sections twelve, twelve-a, and twelve-b of this chapter shall apply to violations of this section, except that the civil penalty for a violation of this section by a cytotechnologist shall not exceed five hundred dollars.

(b) [If a cytotechnologist violates this section, the department may suspend or revoke the cytotechnologist's registration under this section, pursuant to department regulations including appropriate due process protections for the cytotechnologist.

(c)] If any clinical laboratory or other person violating this section is licensed, certified or registered by the department under other provisions of law, the violation of this section may be grounds for disciplining the person under such law.

§ 5. This act shall take effect immediately.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law, in relation to certificates of qualification for clinical laboratories and blood banks

Purpose or general idea of bill

To set specific standards that meet federal requirements so that New York State can be exempt from the Clinical Laboratory Improvement Amend- ments.

Summary of specific provisions

Current law requires clinical laboratory or blood bank directors to have a specialty background in the type of specific testing or activities the facility is engaging in. Sections one through three of this bill would amend the law to require general certificates of qualification rather than specialized ones.

Section four eliminates specific limitations and requirements on cyto- technologists and directs the Department of Health to establish regu- lations for cytotechnologist workload standards that shall be at least as stringent as federal regulations. It also removes the registration requirement for cytotechnologists and the standard for the records cyto- technologists are to maintain under current law.

Section five provides an effective date of immediately.

Justification

The Clinical Laboratory Improvement Amendments of 1988 (CLIA) are feder- al regulations that created standards for US facilities that test human specimens for research or to diagnose or treat disease. It required these facilities to be certified by the US Department of Health and Human Services. However, if a state's requirements are at least as stringent as the federal rules for clinical laboratories, that state can be exempt from CLIA requirements. New York State has been exempted from the CLIA for several years but must reapply for an exemption every six years.

In March of 2021, New York State was told the different sections of law that need to be amended so that the state can remain exempt from CLIA. This legislation amends the public health law to increase the licensing fee, remove certain cytotechnologist requirements, and will clarify the license categories and who can qualify for specific licenses. These changes will ensure that New York State can be granted a CLIA exemption. If the exemption is not granted, this will create a confusing dual registration system in New York for clinical laboratories, causing them to need to apply to two separate programs. The current CLIA exemption expires in March 2027. The application process for the expiration waiver opens in May 2026, so getting this legislation done as quickly as possi- ble allows for the DOH to have time to draft and publish these new regu- lations and ensure they meet federal requirements.

Prior legislative history

New bill.

Fiscal implications

None.

Effective date

This act shall take effect immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.